Lillian Wambuzi Ogwang

Lillian Wambuzi Ogwang

Auto-generated profile, based on publicly available information

Lillian Wambuzi Ogwang

Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 December 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TTTaha E. Taha
Taha E. Taha
NYNonhlanhla Yende-Zuma
Nonhlanhla Yende-Zuma
JAJim Aizire
Jim Aizire
TCTsungai Chipato
Tsungai Chipato
LOLillian Wambuzi Ogwang
Lillian Wambuzi Ogwang
MFMary Glenn Fowler
Mary Glenn Fowler
The PROMOTE study aims to measure long-term antiretroviral treatment (ART) safety and adherence; compare HIV disease progression; assess subsequent adverse pregnancy outcomes; evaluate effect of ART exposure on growth and development in HIV-exposed uninfected children; and assess long-term survival of mothers and children. This report primarily describes cohort characteristics at baseline to better understand long-term outcomes. This is a prospective study. HIV-infected mothers and their children originally recruited in a multisite randomized clinical trial for prevention of perinatal HIV transmission were re-enrolled in PROMOTE. A total of 1987 mothers and 1784 children were enrolled from eight sites in Uganda, Malawi, Zimbabwe and South Africa. Most women (≥75%) reported being married in Malawi and Zimbabwe compared to low proportions in South Africa (4.4% in Durban and 15% in Soweto), and 43.5% in Uganda (p<0.001). There were variabilities in contraceptive practices: injectable contraceptive was the commonest reported method (40.9% overall); implant was the second commonest (15.7% overall); oral contraceptives were common in Zimbabwe; and tubal ligation was common in Malawi and South Africa. At baseline, 97.8% of women reported currently using ART; 96.4% were in WHO clinical class 1 or 2; median CD4 cell count was 825 cells per uL; and viral load was undetectable in 1637 (~85%) of the women. Approximately, 14% of women did not inform their primary partners of their own HIV status, 18% reported that they knew their partners were not HIV tested, and 9% did not know if partner was tested. Overall mean age of children at enrollment was 3.5 years; and 5.7% and 25.0% had weight-for-age and height-for-age z-scores <2 standard deviations, respectively. These baseline data show high adherence to ART use. However, issues of HIV disclosure and reproductive intentions remain important. In addition to ART and ensuring high adherence, other preventive measures should be included.

8 July 2026 in Journal of Developmental & Behavioral Pediatrics
Verified
Journal Article
Closed access
IFItziar Familiar-Lopez
Itziar Familiar-Lopez
ASAlla Sikorskii
Alla Sikorskii
BWBrian Winn
Brian Winn
LWLillian Wambuzi
Lillian Wambuzi
SDSufia Dadabhai
Sufia Dadabhai
MBMichael Boivin
Michael Boivin
Objective: Children with perinatally acquired HIV (PHIV) and those exposed to HIV but uninfected (HEU) are at increased risk for adverse cognitive and behavioral outcomes, particularly in sub-Saharan Africa. This study evaluated the efficacy of brain powered games (BPG), a mobile computerized cognitive rehabilitation intervention, on neurocognitive outcomes among children with PHIV, HEU, and HIV unexposed uninfected children (HUU) in Uganda and Malawi. Methods: We conducted a randomized controlled trial in Uganda and Malawi enrolling 599 children aged 5 to 12 years (PHIV = 120, HEU = 239, HUU = 240). Participants were randomized to a 12-week BPG intervention or a waitlist. Neuropsychological outcomes were assessed at baseline, postintervention, and 6-month follow-up using the Kaufman Assessment Battery for Children Second Edition (KABC-II), test of variables of attention, and Cogstate. Linear mixed-effects models estimated intervention effects, separately by country. Results: In Uganda, children receiving BPG demonstrated higher Learning composite scores (3.34; 95% CI, 1.03–5.65), Mental Processing Index scores (2.39; 95% CI, 0.78–4.01), and Nonverbal Index scores in KABC-II (2.28; 95% CI, 0.27–4.28) immediately postintervention compared with waitlist. Cogstate Maze Learning was higher postintervention (0.02; 95% CI, 0.004–0.043) and at 6 months (0.02; 95% CI, 0.003–0.040). In Malawi, Planning scores (−2.22; 95% CI, −4.39 to −0.05) and Delayed Recall scores (−2.87; 95% CI, −5.22 to −0.51) in KABC-II were lower in the intervention arm postintervention, whereas Cogstate Identification scores were higher (−0.03; 95% CI, −0.05 to −0.004). Conclusion: Mobile cognitive training produced modest, domain-specific cognitive benefits, with effects varying by context and HIV exposure status.